Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Daniel Aaron Pollyea

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Pollyea, Daniel

One or more keywords matched the following items that are connected to Pollyea, Daniel

Item Type	Name
Concept	Sulfonamides
Academic Article	Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.
Academic Article	Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
Academic Article	Shutting Down Acute Myeloid Leukemia and Myelodysplastic Syndrome with BCL-2 Family Protein Inhibition.
Academic Article	Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.
Academic Article	Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.
Academic Article	Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.
Academic Article	Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?
Academic Article	Acute myeloid leukemia drug development in the post-venetoclax era.
Academic Article	How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia.
Academic Article	Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia.
Academic Article	Hypomethylating agents with venetoclax: have we discovered the holy grail?
Academic Article	Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.
Academic Article	Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells.
Academic Article	Venetoclax in AML: Where We Are and Where We Are Headed.
Academic Article	Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study.
Academic Article	The propriety of upgrading responses to venetoclax?+?azacitidine in newly diagnosed patients with acute myeloid leukemia.
Academic Article	New directions for emerging therapies in acute myeloid leukemia: the next chapter.
Academic Article	Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells.
Academic Article	Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.
Academic Article	Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60.
Academic Article	SOHO State of the Art Updates and Next Questions: The Past, Present and Future of Venetoclax-Based Therapies in AML.
Academic Article	Impact of Venetoclax and Azacitidine in Treatment-Na?ve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations.
Academic Article	Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia.
Academic Article	Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax?+?Azacitidine Versus Intensive Chemotherapy.
Academic Article	A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
Academic Article	Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse.

Search Criteria

Sulfonamides